A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal Transplantation

Belatacept, a CTLA4-Ig, was designed to prevent rejection and graft loss in kidney transplant recipients. This immunotherapy showed a long-term clinical benefit mainly on renal function and better glycemic control but was also associated with a higher number of severe infectious diseases, particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Chhun, Stéphanie, Trauchessec, Mathieu, Melicine, Sophie, Nicolas, Frédéric, Miele, Agathe, Lukic, Srboljub, Vilain, Estelle, Amrouche, Lucile, Lebert, Dorothée, Anglicheau, Dany, Tartour, Eric, Zuber, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669563/
https://www.ncbi.nlm.nih.gov/pubmed/38001955
http://dx.doi.org/10.3390/biomedicines11112955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669563/
https://www.ncbi.nlm.nih.gov/pubmed/38001955
http://dx.doi.org/10.3390/biomedicines11112955

Ejemplares similares